Ad is loading...
PCBCX
Price
$11.06
Change
-$0.11 (-0.98%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PCBCX vs RLEFX

Header iconPCBCX vs RLEFX Comparison
Open Charts PCBCX vs RLEFXBanner chart's image
Pioneer Balanced ESG C
Price$11.06
Change-$0.11 (-0.98%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PCBCX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCBCX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCBCX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. PCBCX (423M). RLEFX pays higher dividends than PCBCX: RLEFX (2.42) vs PCBCX (1.27). PCBCX was incepted earlier than RLEFX: PCBCX (19 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. PCBCX (44.00). RLEFX has a lower initial minimum investment than PCBCX: RLEFX (250) vs PCBCX (1000). RLEFX annual gain was more profitable for investors over the last year : 21.09 vs. PCBCX (15.87). RLEFX return over 5 years is better than : 35.95 vs. PCBCX (18.92).
PCBCXRLEFXPCBCX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years9 years-
Gain YTD9.65914.21168%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets423M236B0%
Annual Yield % from dividends1.272.4253%
Returns for 1 year15.8721.0975%
Returns for 3 years-1.4610.95-13%
Returns for 5 years18.9235.9553%
Returns for 10 years21.18N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology